Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

This publication has 160 references indexed in Scilit:

• Natural History of Multiple Sclerosis with Childhood Onset
  New England Journal of Medicine, 2007
• A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
  New England Journal of Medicine, 2006
• Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
  New England Journal of Medicine, 2000
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
  Annals of Neurology, 1996
• Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
  Annals of Neurology, 1995
• Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.
  Journal of Experimental Medicine, 1993
• A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
  Journal of Neurology, Neurosurgery & Psychiatry, 1987
• Molecular and biochemical pharmacology of mitoxantrone
  Cancer Treatment Reviews, 1983
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
  Annals of Neurology, 1983
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
  Annals of the New York Academy of Sciences, 1965